Skip to content
10-Q

Quarterly Report

NASCENT BIOTECH, INC.

0001477932-23-006278

← back to feed
Filed
Aug 18, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Aug 18, 2023 149.64M sh
Current Liabilities Q1 2024 · Jun 30, 2023 $1.23M
Current Liabilities Q1 2024 · Mar 31, 2023 $1.55M
Total Liabilities Q1 2024 · Jun 30, 2023 $1.23M
Total Liabilities Q1 2024 · Mar 31, 2023 $1.55M
Current Assets Q1 2024 · Jun 30, 2023 $78.92K
Current Assets Q1 2024 · Mar 31, 2023 $255K
Total Assets Q1 2024 · Jun 30, 2023 $78.92K
Total Assets Q1 2024 · Mar 31, 2023 $255K
Operating Cash Flow Q1 2024 · Jun 30, 2022 −$343.84K
Stockholders Equity Q1 2024 · Jun 30, 2022 −$1.44M
Stockholders Equity Q1 2024 · Mar 31, 2022 −$671.48K
Rd Expense Q1 2024 · Jun 30, 2022 $56.89K
Net Income Q1 2024 · Jun 30, 2022 −$1.3M
Operating Income Q1 2024 · Jun 30, 2022 −$619.68K